IMM 65 - Portage Biotech
Alternative Names: IMM-65; PORT-3Latest Information Update: 28 Feb 2024
At a glance
- Originator Portage Biotech
- Class Alcohols; Alkanes; Antineoplastics; Cancer vaccines; Ceramides; Ethers; Immunotherapies; Peptide vaccines; Small molecules
- Mechanism of Action Immunostimulants; Natural killer T cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Bladder cancer; Ovarian cancer; Solid tumours